Update on the Clinical and Molecular Characterization of Noonan Syndrome and Other RASopathies: A Retrospective Study and Systematic Review
Authors:
- Giuseppe ReynoldsGRGiuseppe Reynolds
- Andrea GazzinAGAndrea Gazzin
- Diana CarliDCDiana Carli
- Stefania MassurasStefania Massuras
- Simona CardaropoliSimona Cardaropoli
- Maria LucaMLMaria Luca
- Beatrice DefilippiBDBeatrice Defilippi
- Marco TartagliaMTMarco Tartaglia
- Giovanni Battista FerreroGFGiovanni Battista Ferrero
- Alessandro MussaAMAlessandro Mussa
Top Cited Papers
Open Access
- 9 April 2025
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (8) , 3515
Abstract
RASopathies are a diverse group of genetic conditions caused by hyperactivation of the RAS-MAPK signaling pathway, mainly inherited in an autosomal dominant manner. They present with variable features such as short stature, congenital heart defects, facial dysmorphisms, and neurodevelopmental delays. This study retrospectively analyzed 143 cases from 2003 to 2022, aiming to improve genotype–phenotype correlation knowledge for personalized care. Patients with genetically confirmed Noonan syndrome (NS) and related disorders were included, with molecular analysis performed via Sanger or parallel sequencing. Data from 906 previously reported cases were also reviewed. Among the 143 patients, most had NS (n = 116). PTPN11 mutations were most frequent (61%), followed by SOS1 (10.3%) and RAF1 (8.6%). Cardiac anomalies were observed in 71%, with pulmonary stenosis (PS) prevalent in NS (48.3%) and hypertrophic cardiomyopathy (HCM) in NSML (40%). PTPN11 variants were linked to PS and atrial septal defects, SOS1 to multiple cardiopathies, and RAF1 to HCM. Additional features included facial dysmorphisms (74.1%), short stature (62.0%), skeletal anomalies (43.1%), cryptorchidism (59.7%), and brain abnormalities (17.2%). JMML and other malignancies were seen in eight patients. This study emphasizes the importance of genotype-guided care, improved diagnosis of mild cases, and the underrecognized prevalence of neurological anomalies.Keywords
Funding Information
- Italian National Association of Noonan Syndrome and RASopathies
- Italian Ministry of Health (Current Research Funds)
This publication has 108 references indexed in Scilit:
- Variable phenotypic expression in a large Noonan syndrome family segregating a novel SOS1 mutationAmerican Journal of Medical Genetics Part A, 2017
- Noonan syndrome in diverse populationsAmerican Journal of Medical Genetics Part A, 2017
- Variability in clinical and neuropsychological features of individuals with MAP2K1 mutationsAmerican Journal of Medical Genetics Part A, 2016
- A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hairAmerican Journal of Medical Genetics Part A, 2016
- Occurrence of DNET and other brain tumors in Noonan syndrome warrants caution with growth hormone therapyAmerican Journal of Medical Genetics Part A, 2015
- Further evidence of the importance of RIT1 in Noonan syndromeAmerican Journal of Medical Genetics Part A, 2014
- Multiple café au lait spots in familial patients with MAP2K2 mutationAmerican Journal of Medical Genetics Part A, 2013
- Genotypic and phenotypic characterization of Noonan syndrome: New data and review of the literatureAmerican Journal of Medical Genetics Part A, 2005
- Multiple Lentigenes SyndromeAmerican Journal of Diseases of Children, 1969
- Hypertelorism With Turner PhenotypeAmerican Journal of Diseases of Children, 1968